New Blood Test Strategy Could Catch Type 1 Diabetes Earlier Than Ever Before

Type 1 diabetes typically isn't diagnosed until significant damage has already occurred to insulin-producing beta cells. Once symptoms like thirst and fatigue appear, much of the disease process is already underway. This timing challenge is why researchers have long searched for ways to identify type 1 diabetes during its hidden, presymptomatic phase—when the immune system is actively attacking beta cells but before clinical symptoms emerge.

The ability to catch type 1 diabetes earlier could be transformative. It would create a window of opportunity for interventions designed to slow or prevent further beta cell damage, potentially preserving the body's remaining insulin production.

Researchers developed a strategy using dried blood spots (DBS)—tiny samples of blood collected on filter paper at home, similar to newborn screening tests. The key innovation was frequent sampling: researchers collected blood samples every one to five days rather than at occasional clinic visits.

This frequent monitoring revealed something important: rapid, temporary changes in blood proteins that occur during early disease development. These transient molecular shifts would have been missed by standard testing intervals. The researchers analyzed the blood using a technique called proximity extension assay, which measures many proteins simultaneously in very small samples.

In a mouse model of type 1 diabetes, the frequent blood sampling strategy uncovered specific patterns of protein changes following viral infection—a suspected trigger for type 1 diabetes. A computer learning model trained on these protein patterns could predict disease status with over 90% accuracy starting just two days after infection.

The research also demonstrated that early detection could potentially guide treatment timing. When researchers treated infected mice at specific early time points, they observed effects on diabetes development, suggesting that precise timing of intervention might matter.

This research represents an important proof-of-concept in mice, demonstrating that frequent blood sampling and protein analysis can reveal early disease markers. However, human studies are essential before this approach could be used in clinical practice to identify people at risk for type 1 diabetes.

If validated in people, this strategy could help identify individuals in the presymptomatic phase of type 1 diabetes and potentially enable timely interventions. It also highlights the value of frequent, convenient home-based monitoring in understanding how type 1 diabetes develops.

Source: Diabetologia. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.